Literature DB >> 12907389

Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus.

Katherine A Thompson1, Stephen J Kent, Michelle E Gahan, Damian F J Purcell, Catriona A McLean, Scott Preiss, C Jane Dale, Steven L Wesselingh.   

Abstract

Simian immunodeficiency virus (SIV) infection of macaques results in neurological abnormalities similar to those of human immunodeficiency virus (HIV)-associated dementia in humans and is a valuable system for the identification of viral neurotropic and neurovirulence factors. The authors recently established an SIV-macaque model where macaques can be infected with wild-type or nef/LTR-deleted SIVmac239 via administration of purified proviral DNA. In this study, the ability of wild-type and nef/LTR-deleted SIV infections to enter the cerebral spinal fluid (CSF) and brain was analyzed. In situ polymerase chain reaction (PCR) readily detected SIV gag DNA-positive cells in the mid-frontal gyrus and basal ganglia of the wild-type SIV-infected macaques, but not in nef/LTR-deleted SIV-infected or SIV-uninfected macaques. PCR on extracted DNA confirmed the in situ results, with multiple brain regions of the wild-type SIV-infected macaques positive for both gag and wild-type nef, whereas in the nef/LTR-deleted SIV-infected macaques, nef/LTR and gag DNA were undetectable. Further, macaques infected with nef/LTR-deleted SIV, which later became superinfected with wild-type SIV, also remained negative for SIV DNA in the brain by both in situ and extracted DNA techniques, despite having high levels of SIV RNA both in the CSF and plasma. This study provides evidence of the inability of nef/LTR-deleted SIV to initiate central nervous system (CNS) infection and suggests that, in the brain regions examined, nef/LTR-deleted viruses have either diminished neurotropism or insufficient systemic viral replication for entry into the CNS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907389     DOI: 10.1080/13550280390218715

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  23 in total

1.  Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV.

Authors:  M Demuth; S Czub; U Sauer; E Koutsilieri; P Haaft; J Heeney; C Stahl-Hennig; V ter Meulen; S Sopper
Journal:  J Neurovirol       Date:  2000-06       Impact factor: 2.643

2.  Vaccination with attenuated simian immunodeficiency virus by DNA inoculation.

Authors:  S J Kent; C J Dale; S Preiss; J Mills; D Campagna; D F Purcell
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

Authors:  J C Learmont; A F Geczy; J Mills; L J Ashton; C H Raynes-Greenow; R J Garsia; W B Dyer; L McIntyre; R B Oelrichs; D I Rhodes; N J Deacon; J S Sullivan
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

4.  High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.

Authors:  R Mariani; F Kirchhoff; T C Greenough; J L Sullivan; R C Desrosiers; J Skowronski
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group.

Authors:  D I Rhodes; L Ashton; A Solomon; A Carr; D Cooper; J Kaldor; N Deacon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 (HIV-1)-specific T cell responses correlate with control of acute HIV-1 infection in macaques.

Authors:  S J Kent; A Woodward; A Zhao
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

7.  Evidence of recombination between 3' and 5' LTRs in macaques inoculated with SIV DNA.

Authors:  Stephen J Kent; C Jane Dale; Scott Preiss; Damian F J Purcell
Journal:  AIDS Res Hum Retroviruses       Date:  2002-02-10       Impact factor: 2.205

8.  Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.

Authors:  S J Kent; A Zhao; S J Best; J D Chandler; D B Boyle; I A Ramshaw
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.

Authors:  A K Iversen; E G Shpaer; A G Rodrigo; M S Hirsch; B D Walker; H W Sheppard; T C Merigan; J I Mullins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more
  14 in total

1.  Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia.

Authors:  Melissa J Churchill; Anna Figueiredo; Daniel Cowley; Lachlan Gray; Damian Fj Purcell; John S Sullivan; Dale A McPhee; Steven L Wesselingh; Bruce J Brew; Paul R Gorry
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

2.  Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques.

Authors:  Susanna L Lamers; David J Nolan; Brittany D Rife; Gary B Fogel; Michael S McGrath; Tricia H Burdo; Patrick Autissier; Kenneth C Williams; Maureen M Goodenow; Marco Salemi
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

Review 3.  Paving the path to HIV neurotherapy: Predicting SIV CNS disease.

Authors:  Sarah E Beck; Suzanne E Queen; Kenneth W Witwer; Kelly A Metcalf Pate; Lisa M Mangus; Lucio Gama; Robert J Adams; Janice E Clements; M Christine Zink; Joseph L Mankowski
Journal:  Eur J Pharmacol       Date:  2015-03-24       Impact factor: 4.432

4.  Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.

Authors:  Kenta Matsuda; Chia-Yen Chen; Sonya Whitted; Elena Chertova; David J Roser; Fan Wu; Ronald J Plishka; Ilnour Ourmanov; Alicia Buckler-White; Jeffrey D Lifson; Klaus Strebel; Vanessa M Hirsch
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

5.  CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.

Authors:  Lachlan R Gray; Dana Gabuzda; Daniel Cowley; Anne Ellett; Lisa Chiavaroli; Steven L Wesselingh; Melissa J Churchill; Paul R Gorry
Journal:  J Neurovirol       Date:  2010-11-30       Impact factor: 2.643

6.  Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.

Authors:  Ronald A Cohen; Suzanne de la Monte; Assawin Gongvatana; Hernando Ombao; Beverly Gonzalez; Kathryn N Devlin; Bradford Navia; Karen T Tashima
Journal:  J Neuroimmunol       Date:  2010-12-10       Impact factor: 3.478

7.  Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence.

Authors:  Thórdur Oskarsson; Hulda S Hreggvidsdóttir; Gudrún Agnarsdóttir; Sigrídur Matthíasdóttir; Margrét H Ogmundsdóttir; Stefán R Jónsson; Gudmundur Georgsson; Sigurdur Ingvarsson; Olafur S Andrésson; Valgerdur Andrésdóttir
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 8.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

Review 9.  An SIV/macaque model targeted to study HIV-associated neurocognitive disorders.

Authors:  Sarah E Beck; Suzanne E Queen; Kelly A Metcalf Pate; Lisa M Mangus; Celina M Abreu; Lucio Gama; Kenneth W Witwer; Robert J Adams; M Christine Zink; Janice E Clements; Joseph L Mankowski
Journal:  J Neurovirol       Date:  2017-10-03       Impact factor: 2.643

10.  HIV-1 nef protein structures associated with brain infection and dementia pathogenesis.

Authors:  Susanna L Lamers; Art F Y Poon; Michael S McGrath
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.